WOLVERINE ASSET MANAGEMENT LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$4,278,000
+400.9%
92,346
+54.0%
0.06%
+460.0%
Q4 2018$854,000
+238.9%
59,984
+261.3%
0.01%
+233.3%
Q3 2018$252,000
-9.4%
16,6000.0%0.00%
-25.0%
Q2 2018$278,000
-49.8%
16,600
-51.2%
0.00%
-42.9%
Q1 2018$554,000
-85.0%
34,000
-88.2%
0.01%
-81.6%
Q4 2017$3,693,000
+30.8%
288,600
+25.7%
0.04%
+22.6%
Q3 2017$2,824,000
+53.6%
229,600
+4.6%
0.03%
+34.8%
Q2 2017$1,838,000
-14.3%
219,600
-8.5%
0.02%
-32.4%
Q1 2017$2,144,000
+11.0%
240,000
+9.1%
0.03%
+36.0%
Q4 2016$1,932,000
+37.6%
219,900
+5.7%
0.02%
+19.0%
Q3 2016$1,404,000
+156.7%
208,100
+35.3%
0.02%
+162.5%
Q2 2016$547,000
+21.8%
153,800
+4193.7%
0.01%
-38.5%
Q1 2016$449,000
+87.1%
3,582
+33.6%
0.01%
+160.0%
Q4 2015$240,000
+133.0%
2,682
+194.7%
0.01%
+150.0%
Q3 2015$103,000
-20.8%
910
-61.2%
0.00%
-33.3%
Q2 2015$130,000
-16.1%
2,346
+19.2%
0.00%
-25.0%
Q1 2015$155,000
+416.7%
1,968
+47.2%
0.00%
+300.0%
Q4 2014$30,000
-88.7%
1,337
-77.6%
0.00%
-83.3%
Q3 2014$266,000
+1377.8%
5,977
+2400.8%
0.01%
Q2 2014$18,000
-92.2%
239
-93.7%
0.00%
-100.0%
Q1 2014$230,000
+198.7%
3,818
+66.8%
0.01%
+150.0%
Q4 2013$77,000
-63.5%
2,289
-66.6%
0.00%
-60.0%
Q3 2013$211,0006,8630.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders